Abstract
This chapter is about recurrence and complications after laser coagulation and anti-VEGF treatment. Recurrence and complications are very different in both treatment modalities and it is very important to know them.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mintz-Hittner HA, Geloneck MM, Chuang AZ. Clinical management of recurrent retinopathy of prematurity after Intravitreal Bevacizumab monotherapy. Ophthalmology. 2016;123(9):1845–55.
Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364:603–15.
Feng J, Qian J, Jiang Y, Zhao M, Liang J, Yin H, Chen Y, Yu W, Li X. Efficacy of primary Intravitreal Ranibizumab for retinopathy of prematurity in China. Ophthalmology. 2017;124(3):408–9.
Hu J, Blair MP, Shapiro MJ, Lichetnstein SJ, Galasso JM, Kapur R. Reactivation of retinopathy of prematurity after Bevacizumab injection. Arch Ophthalmol. 2012;130(8):1000–6.
Early Treatment for Retinopathy of Prematurity Cooperative Group, Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Tung B, Redford M. Final visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol. 2010;128(6):663–71.
Holmström G, Hellström A, Jakobsson P, Lundgren P, Tornqvist K, Wallin A. Five years of treatment for retinopathy of prematurity in Sweden: results from SWEDROP, a national quality register. Br J Ophthalmol. 2016;100(12):1656–61.
Garcia Gonzalez JM, Snyder L, Blair M, Rohr A, Shapiro M, Greenwald M. Prophylactic peripheral laser and fluorescein angiography after bevacizumab for retinopathy of prematurity. Retina. 2018;38(4):764–72.
Holmström G, Tornqvist K, Al-Hawasi A, Nilsson Å, Wallin A, Hellström A. Increased frequency of retinopathy of prematurity over the last decade and significant regional differences. Acta Ophthalmol. 2018;96(2):142–8.
Repka MX, Tung B, Good WV, Shapiro M, Capone A Jr, Baker JD, Barr CC, Phelps DL. van. Thomas BJ, Yonekawa Y, Trese MT. Complete resolution of large retinal fold after transection of retrolental membrane during lens-sparing vitrectomy for retinopathy of prematurity: a 15-year follow-up. Retin Cases Brief Rep. 2016;10(1):93–5.
Bakri SJ, Snyder MR, Reid JM, et al. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology. 2007;114:855–9.
Hu Q, Bai Y, Chen X, Huang L, Chen Y, Li X. Recurrence of retinopathy of prematurity in Zone II Stage 3+ after Ranibizumab treatment: a retropspective study. Ophthalmol. 2017;2017:5078565. Published online 2017 Apr 9. https://doi.org/10.1155/2017/5078565.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Spandau, U., Kim, S.J. (2019). Recurrence and Complications After Laser Coagulation and Anti-VEGF Treatment. In: Pediatric Retinal Vascular Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-13701-4_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-13701-4_17
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-13700-7
Online ISBN: 978-3-030-13701-4
eBook Packages: MedicineMedicine (R0)